• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

Chemical Profile of 2-(4-Isopropylphenoxy)-2-methylpropanoic acid (CAS No. 669747-64-2)

2-(4-Isopropylphenoxy)-2-methylpropanoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 669747-64-2, is a specialized organic compound that has garnered attention in the field of pharmaceutical chemistry and biochemical research. This compound belongs to the class of phenoxyacetic acid derivatives, characterized by its unique structural motif that combines a phenolic ether moiety with a branched alkanoic acid backbone. The presence of an isopropyl group at the para position of the phenyl ring and a secondary butyl ester-like structure contributes to its distinct chemical properties, making it a subject of interest for synthetic chemists and biologists exploring novel molecular architectures.

The molecular structure of this compound exhibits a balance between lipophilicity and polarizability, which is critical for its potential applications in drug design and biochemical interactions. The phenoxyl group, linked to a tertiary carbon atom via an ether bond, suggests possible roles in protein-protein interactions or as a bioisostere for other pharmacophoric elements. Meanwhile, the branched alkanoic acid moiety introduces steric hindrance that could influence binding affinities and metabolic stability.

In recent years, derivatives of phenoxyacetic acids have been extensively studied for their biological activities, including roles as growth factor inhibitors, receptor modulators, and intermediates in the synthesis of therapeutic agents. The specific substitution pattern in 2-(4-Isopropylphenoxy)-2-methylpropanoic acid positions it as a candidate for further exploration in these areas. For instance, modifications at the isopropyl-substituted aromatic ring could alter electronic properties, affecting interactions with biological targets such as enzymes or receptors.

One notable application area is in the development of bioactive molecules targeting neurological disorders. Phenoxyacetic acid derivatives have shown promise as modulators of neurotransmitter systems, particularly in contexts involving dopamine or serotonin pathways. The structural features of CAS No. 669747-64-2 may enable it to interact with specific binding sites on neurotransmitter receptors or transporters, potentially leading to novel therapeutic strategies for conditions like depression or neurodegeneration.

From a synthetic chemistry perspective, this compound serves as an interesting scaffold for generating libraries of analogs through functional group modifications. The presence of both an ether linkage and an acidic carboxyl group allows for diverse derivatization strategies, including esterification, amidation, or alkylation. Such modifications can fine-tune physicochemical properties like solubility, bioavailability, and metabolic clearance—key factors in drug development.

Recent advances in computational chemistry have enabled virtual screening approaches to identify potential leads like 2-(4-Isopropylphenoxy)-2-methylpropanoic acid for biological assays. Molecular docking simulations can predict binding modes and affinities with high precision, allowing researchers to prioritize compounds for experimental validation. This high-throughput virtual screening has accelerated the discovery process in drug discovery pipelines.

The compound’s potential role in drug metabolism also warrants investigation. Given its structural complexity, it may undergo biotransformation via cytochrome P450 enzymes or glucuronidation pathways. Understanding these metabolic routes is essential to assess its safety profile and optimize dosing regimens if it were to progress into clinical applications.

In academic research circles, this molecule has been employed as a reference standard or intermediate in synthetic methodologies targeting more complex scaffolds. Its unique reactivity patterns under various chemical conditions make it valuable for teaching purposes and methodological development in organic synthesis labs.

The growing emphasis on green chemistry principles has prompted investigations into sustainable synthetic routes for such compounds. Researchers are exploring catalytic processes that minimize waste generation while maintaining high yields—a critical consideration for industrial-scale production.

Future directions may include exploring pharmaceutical applications in oncology or anti-inflammatory therapies. The ability to modify key pharmacophoric groups on this scaffold could yield compounds with enhanced efficacy against disease-causing pathways while reducing off-target effects.

In conclusion,CAS No. 669747-64-2 (2-(4-Isopropylphenoxy)-2-methylpropanoic acid) represents a promising chemical entity with diverse potential uses spanning medicinal chemistry and biochemical research. Its structural features invite further exploration into biological activities and synthetic applications that could contribute significantly to advancements across multiple scientific disciplines.

• 62402-50-0(Propanoic acid, 2-methyl-2-[4-(1-phenylethyl)phenoxy]-, ethyl ester)
• 76674-58-3(2-(4-tert-Butylphenoxy)-2-methylpropanoic Acid)
• 70757-66-3(2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid)
• 2012-73-9(2-Methyl-2-4-(1-methyl-1-phenylethyl)phenoxypropanoic Acid)
• 97283-84-6(2-(2-Isopropyl-5-methylphenoxy)-2-methylpropanoic acid)
• 23438-11-1(2-Methyl-2-(4-methylphenoxy)propanoic Acid)
• 111396-81-7(Propanoic acid,2-methyl-2-(3-pentadecylphenoxy)-)
• 237412-04-3(2-(4-Isopropylphenoxy)propanoic acid)
• 53498-64-9(2-Methyl-2-(3-methylphenoxy)propanoic Acid)
• 62402-52-2(Propanoic acid, 2-[4-(hydroxyphenylmethyl)phenoxy]-2-methyl-)